Contents. Contributors. Reviewers. Acknowledgements I CARDIOVASCULAR COMPLICATIONS

Similar documents
2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types

2018 OCN Keywords January 22, 2018 Subject Area Weight Keywords

Index. Note: Page numbers of article titles are in boldface type.

Oncologic Emergencies

COURSE OUTLINE Pathophysiology

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type.

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

Palliative Care Emergencies. Dr Debbie Quinn Associate Specialist in Palliative Medicine, Isabel Hospice

PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION

Referral guide for acute oncology emergencies

MabThera. SC. The wait is over. MabThera delivered in just 5 minutes. SC= subcutaneous injection

Oncologic Emergencies: When to call the Radiation Oncologist

Pharmacotherapy Handbook

Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification

Hospice and Palliative Medicine

SHOCK AETIOLOGY OF SHOCK (1) Inadequate circulating blood volume ) Loss of Autonomic control of the vasculature (3) Impaired cardiac function

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Clinical Trial Results Database Page 1

Breast Pathway Group Bevacizumab & Paclitaxel in Advanced Breast Cancer

Bachelor of Chinese Medicine Shock

Index. Note: Page numbers of article numbers are in boldface type.

2017 ACCP/SCCM Critical Care Preparatory Review and Recertification Course Learning Objectives

BEVACIZUMAB in Ovarian cancer. Cancer drug fund application and approval is required for funding. Continue Bevacizumab treatment for up to 18 cycles.

Gastrointestinal obstruction Dr Iain Lawrie

Blood products and plasma substitutes

DERBY-BURTON CANCER NETWORK CONTROLLED DOC NO:

Online Supplementary Data. Country Number of centers Number of patients randomized

Rituximab (weekly) for Primary Cutaneous B cell Lymphoma

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

STEROID GUIDELINES AUDIT RESULTS

Haematological Emergencies (Part 1) Ray Mun Koo Haematology Advanced Trainee Canberra Hospital

Index. Note: Page numbers of article titles are in boldface type.

Approach to disseminated intravascular coagulation

Handbook for Venous Thromboembolism

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

Appendix Criteria used for the automated chart review

Hospice Skills Checklist

Table of Contents. Course CME Credits. General Principles Topic CME Credit(s)

MASTER SYLLABUS. 3. Recall and discuss the incredible role that the immune system plays in maintaining health and overcoming disease.

Wales Critical Care & Trauma Network (North) Management of Hyponatraemia in Intensive Care Guidelines

Oncology Skills Checklist

Department of Anesthesiology. Clinical Base Year Neurosurgery Curriculum. Residency Program Director Department of Neurosurgery

Medical APMLE. Podiatry and Medical.

Emergencies in Palliative Medicine

ICD-10 Physician Education. Palliative Care SIP

Lung Cancer - Suspected

High-Acuity Nursing. Global edition. Global edition. Kathleen Dorman Wagner Melanie G. Hardin-Pierce

POMALONG Capsules (Pomalidomide)

Obinutuzumab+Bendamustine followed by Obinutuzumab Maintenance Burton in-patient Derby in-patient Burton day-case Derby day-case

Professor Dr. Saiyeedur Rahman Professor and Head Department of Medicine SBMCH, Barisal

REMS Council Quality Improvement Committee Incident Disposition Summary FY2015 Quarter 3 (January March, 2015)

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

LIVER DIRECTED THERAPY IN UVEAL MELANOMA- THE SOUTHAMPTON EXPERIENCE

Ischemic Stroke in Critically Ill Patients with Malignancy

Module Three Core skills in cancer care. Overview

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

LeMone & Burke Ch 30-32

Hyponatraemia: confident diagnosis, effective treatment and avoiding disasters. Dr James Ahlquist Endocrinologist Southend Hospital

Oncology Competency Self Assessment

Safe Answers For The American Board of Surgery Certifying Exam & Recertifying Exam

Hemodynamic Disorders Thrombosis and Shock. 1. Interstitial, between the cells, but outside of the vascular system. - water making up the blood and

Shock Management. Seyed Tayeb Moradian MSc, Critical Care Nursing Ph.D Candidate. PDF created with pdffactory Pro trial version

Carfilzomib and Dexamethasone (CarDex)

PFIZER INC. Study Center(s): A total of 6 centers took part in the study, including 2 in France and 4 in the United States.

CASE STUDY. Presented by: Jessica Pizzo. CFCC Sonography student Class of 2018

Unrestricted. Dr ppooransari fellowship of perenatalogy

TCHP Docetaxel, Carboplatin, Trastuzumab, Pertuzumab Neoadjuvant Protocol

BAPTIST HEALTH SCHOOL OF NURSING NSG 3026A: CHILDREN S HEALTH

Mabel Labrada, MD Miami VA Medical Center

Emergency Department Suite

Dr. Nai Shun Tsoi Department of Paediatric and Adolescent Medicine Queen Mary Hospital Hong Kong SAR

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism

ACCP/SCCM Critical Care Preparatory Review and Recertification Course Learning Objectives

Unit 4 Problems of Cardiac Output and Tissue Perfusion

Spinal Cord Compression Diagnosis and Management. Information for Shared Care Centres and Community Staff

Transfusion Requirements and Management in Trauma RACHEL JACK

Cancer of Unknown Primary (CUP) Protocol

4. Which survey program does your facility use to get your program designated by the state?

Index. Note: Page numbers of article titles are in boldface type.

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives

Palliative Care Emergencies

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

0BCore Safety Profile

UCLA General Surgery Residency Program Rotation Educational Policy Goals and Objectives ROTATION: SURGICAL CRITICAL CARE AND TRANSPLANTATION SURGERY

North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO)

THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST

Long Term Follow-up. 6 Month 1 Year Annual enter year #: What is the assessment date: / / Unknown. Is the patient alive? Yes No

MEDICAL FACULTY DEPARTMENT OF PATHOPHYSIOLOGY QUESTION FOR ORAL PART OF EXAM MEDICAL STUDENTS

Acute Oncology. Protocols & Competencies Acute Oncology Introduction

SCHOOL OF RADIOGRAPHY

New Strategies in the Management of Patients with Severe Sepsis

InterQual Level of Care 2018 Index

Australian College of Veterinary Scientists. Membership Examinationn. Veterinary Emergency and Critical Care Paper 1

Disturbance of Circulation Hemodynamic Disorder

Specific Basic Standards for Osteopathic Fellowship Training in Pulmonary / Critical Care Medicine

FUJI study: Follow-Up of Jevtana in real life

Ontario s Paediatric Referral and Listing Criteria for Small Bowel and Liver- Small Bowel Transplantation

Transcription:

Contributors Reviewers Acknowledgements Preface xii xvi xvii xviii I CARDIOVASCULAR COMPLICATIONS 1 Cardiac Complications of Cancer and Anticancer Treatment 3 Introduction 3 Malignant Pericardial Effusion and Cardiac Tamponade 3 Chemotherapy-related Heart Failure 5 Arterial Hypertension 10 Myocardial Ischaemia 12 Arrhythmias 13 QT Prolongation 14 Radiation Therapy-induced Cardiotoxicity 15 Further Reading 16 2 Venous Thromboembolism in Cancer Patients 17 Introduction 17 Pathophysiology 18 Diagnosis 20 Prevention of Cancer-associated Thromboembolism 22 Treatment 23 Further Reading 28 v

3 Superior Vena Cava Syndrome 30 Introduction 30 Physiology of SVC Obstruction (SVCO) 30 Aetiology 31 Investigations 32 Treatment 34 Summary 38 Further Reading 38 4 Complications of Central Venous Devices 39 Introduction 39 Intravascular Catheter-related Infections 39 Catheter-related Thrombosis 45 Catheter Malfunction 47 Further Reading 47 5 Septic Shock 49 Definition 49 Management of Septic Shock 49 Antimicrobial Therapy 51 Treatment of Cardiovascular Insufficiency 53 Oxygen Support 54 Nutrition 55 Hyperglycaemia 55 Treatment with Corticosteroids 55 Treatment with Coagulation Inhibitors 55 Cytokines and Haematopoietic Growth Factors 56 Transfusion Management in Sepsis 56 Further Reading 56 6 Extravasation of Chemotherapy 58 Introduction 58 Differential Diagnosis and Grading 58 Epidemiology 59 Risk Factors Intravenous Infusion 59 Management 63 vi

Documentation and Follow-up 66 Further Reading 68 II NEUROLOGICAL COMPLICATIONS 7 Spinal Cord Compression 71 Introduction 71 Clinical Manifestations 72 Evaluation of SCC 72 Differential Diagnosis 72 Management 73 Further Reading 76 8 Complications of Brain Metastases 77 Introduction 77 Evaluation and Treatment of Brain Metastases 77 Important Complications of Brain Metastases 78 Leptomeningeal Carcinomatosis 81 Future Strategies 81 Further Reading 82 III RENAL AND UROLOGICAL COMPLICATIONS 9 Renal Failure and Urological Emergencies in Cancer Patients 85 Introduction 85 Urological Emergencies 85 Acute Renal Failure 88 Further Reading 90 IV METABOLIC COMPLICATIONS 10 Hypercalcaemia 95 Definition 95 Aetiology 95 Differential Diagnosis 96 Evaluation 97 vii

Treatment 98 Further Reading 101 11 Tumour Lysis Syndrome 103 Introduction 103 Signs and Symptoms 105 Risk Stratification 105 Prevention 107 Treatment 111 Further Reading 112 12 Other Endocrine and Metabolic Complications of Advanced Cancer 114 Hyponatraemia and the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) 114 Lactic Acidosis 119 Hypoglycaemia 120 Complication of Forced Diuresis 121 Further Reading 122 V RESPIRATORY COMPLICATIONS 13 Dyspnoea and Respiratory Failure 125 Introduction 125 Aetiology 126 Evaluation 127 Anamnesis of Dyspnoea 127 Clinical Examination 129 Complementary Investigations 130 Evaluation of Tolerance 130 Management of Dyspnoea 131 Further Reading 134 14 Pulmonary Infections in Cancer 136 Introduction 136 Aetiology 136 viii

Clinical Manifestations and Presentations 137 Diagnosis 139 Treatment 140 Conclusions 142 Further Reading 143 15 Haemoptysis and Intractable Hiccups 144 Haemoptysis 144 Persistent and Intractable Hiccups 148 Further Reading 152 VI GASTROINTESTINAL COMPLICATIONS 16 Nausea and Vomiting 157 Introduction 157 Aetiology 158 Pathophysiology 160 Risk factors 160 Obstructive Bowel Disease 161 Treatment 161 Further Reading 163 17 Mucositis 164 Definition 164 Technical Procedures Involved 165 Description of the Processes Involved in Their Essential/Critical Steps 166 Management of OM 167 Potential Future Developments 170 Further Reading 171 18 Diarrhoea 172 Introduction 172 Oncological Therapies Associated with Diarrhoea 173 Other Causes of Diarrhoea in Cancer Patients 177 Patient Assessment 178 ix

Management and Treatment 179 Conclusions 181 Further Reading 181 19 Abdominal Infections in Neutropaenic Patients 183 Introduction 183 Definitions 184 Risk Factors 185 Pathophysiology 186 Clinical Manifestations 187 Diagnosis 188 Management 191 Conclusion 193 Further Reading 193 VII IMMUNE HAEMATOLOGICAL EMERGENCIES 20 Anaemia in Cancer 197 Introduction 197 Aetiology 197 Evaluation 198 Treatment 201 Iron Supplementation 206 Conclusion 206 Further Reading 207 21 Febrile Neutropaenia in Cancer Patients 208 Aetiology and Epidemiology 208 Initial Assessment and Investigations 209 Risk Factors/Risk Groups 210 Treatment 212 Follow-up and Duration of Therapy 217 Further Reading 218 22 Immune Haematological Emergencies in Cancer Patients 221 Drug-induced Hypersensitivity 221 x

Infusion-related Reactions with Drugs 223 Adverse Transfusion Reactions with Blood Components 226 Disseminated Intravascular Coagulation 228 Further Reading 231 23 Bleeding Disorders 233 Introduction 233 Aetiology 234 Evaluation 236 Prevention and Treatment 238 Conclusion 242 Further Reading 242 VIII CANCER PAIN 24 Management of Cancer Pain 245 Introduction 245 Basic Science of Pain 245 Aetiology 246 Evaluation 247 Treatment 249 Further Reading 258 IX PSYCHOLOGICAL COMPLICATIONS 25 Psychological Complications 263 Definition 263 Description of the Process 264 Technical Procedures Involved 266 Predictive and Prognosis Markers 267 Clinical Results 269 Potential Future Developments 270 Further Reading 270 Index 272 xi